Better liver cancer screening with GAAD score and imaging
Part of Cancer, Digestive system clinical trials.
This study looks at whether adding a blood test (the GAAD score) to standard imaging can better detect liver cancer at an early stage in people with chronic liver disease. It may help you if you have cirrhosis or certain types of liver scarring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (scarring of the liver) or certain types of chronic liver disease with advanced scarring.
- You have not had liver cancer (HCC) in the past.
- You are able to have both a CT scan and an MRI.
- Your kidney function is good enough (GFR above 45).
- You are not pregnant or breastfeeding, and you are not taking blood thinners called vitamin K antagonists.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This study checks if a simple score (FIB-4) can help find early liver cancer in people with type 2 diabetes. It aims to see if regular monitoring could help catch cancer sooner.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
Hear when a new Cancer, Hepatocellular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.